{"id":"W4200343608","doi":"10.1161/jaha.121.023143","title":"Efficacy and Safety of Antithrombotic Therapy in Patients With Atrial Fibrillation, Recent Acute Coronary Syndrome, or Percutaneous Coronary Intervention and a History of Heart Failure: Insights From the AUGUSTUS Trial","year":2021,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta; St. Michael's Hospital","funders":"Janssen Pharmaceuticals; Amgen; Roivant Sciences; Sirtex Medical; Regeneron Pharmaceuticals; National Institutes of Health; Bristol-Myers Squibb; CryoLife; Medtronic; Claret Medical; Novo Nordisk; Medicines Company; Abbott Vascular; Zafgen; Boston Scientific Corporation; Eli Lilly and Company; AstraZeneca; CSL Behring; Daiichi Sankyo Europe; Gilead Sciences; Sanofi; GlaxoSmithKline; Edwards Lifesciences; National Heart, Lung, and Blood Institute; Pfizer","keywords":"Antithrombotic; Percutaneous coronary intervention; Atrial fibrillation; Acute coronary syndrome; Clinical trial; Percutaneous; Randomized controlled trial; Coronary heart disease; Anticoagulant","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002497043,0.000713894,0.00188991,0.000307822,0.0003561769,0.001397699,0.0005930529,0.00128542,0.001746691],"category_scores_gemma":[0.005405059,0.0003302704,0.001949514,0.0004897929,0.0006996821,0.00100633,0.0008402302,0.001760436,0.0002353974],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005379956,"about_ca_system_score_gemma":0.0005716528,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000947179,"about_ca_topic_score_gemma":0.002407022,"domain_scores_codex":[0.9987184,0.0007093433,0.000139039,0.0001575249,0.000138321,0.000137364],"domain_scores_gemma":[0.9970616,0.001125258,0.0009777098,0.0002273138,0.0001121978,0.000495977],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.4407123,0.006325766,0.4463755,0.002178589,0.02284108,0.0003759258,0.000450185,0.001470011,0.002412926,0.001701328,0.007465522,0.06769093],"study_design_scores_gemma":[0.13642,0.02139252,0.8101043,0.0006618221,0.018519,0.0005117209,0.0004004916,0.002192545,0.0005362661,0.002785429,0.006313082,0.0001627544],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9862298,0.0092974,0.00009640168,0.001409476,0.0001956849,0.0000688691,0.0006069904,0.000011433,0.002083986],"genre_scores_gemma":[0.9932624,0.00320134,0.0002991878,0.0008956682,0.0007427093,0.000114346,0.001014153,0.000007279974,0.0004629038],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002497043,"threshold_uncertainty_score":0.01320583,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02018648720904967,"score_gpt":0.2771613694230604,"score_spread":0.2569748822140108,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}